Schuppenflechte
Schuppenflechte

Ursachen, Symptome, Diagnose & Behandlung

Ekzem
Ekzem

Ekzeme sind Entzündungen der Haut. Es gibt 3 verschiedene Formen

Medikamente gegen Neurodermitis
Medikamente gegen Neurodermitis

Welche Medikamente bei Neurodermitis helfen, hängt von der Stufe der Erkrankung ab. Ein Überblick über Cortison und alternative Wirkstoff

Symptom Juckreiz
Symptom Juckreiz

Juckreiz ist eine Missempfindung der Haut, die flächendeckend, chronisch & örtlich auftreten kann. Er kann auf ernste Grunderkrankungen hindeuten

Quellen

  1. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. The Journal of investigative dermatology. 2013;133(2):377-85.
  2. Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV. 2017;31(2):205-12.
  3. Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. Journal of the American Academy of Dermatology. 2009;60(3):394-401.
  4. Strange A, Capon F, Spencer CC, Knight J, Weale ME, Allen MH, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nature genetics. 2010;42(11):985-90.
  5. Mahil SK, Capon F, Barker JN. Genetics of psoriasis. Dermatologic clinics. 2015;33(1):1-11.
  6. Bremmer S, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Young M, et al. Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 2010;63(6):1058-69.
  7. Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Archives of dermatology. 1999;135(12):1490-3.
  8. Qureshi AA, Dominguez PL, Choi HK, Han J, Curhan G. Alcohol intake and risk of incident psoriasis in US women: a prospective study. Archives of dermatology. 2010;146(12):1364-9.
  9. Higgins E. Alcohol, smoking and psoriasis. Clinical and experimental dermatology. 2000;25(2):107-10.
  10. van der Velden HM, Klaassen KM, van de Kerkhof PC, Pasch MC. Fingernail psoriasis reconsidered: a case-control study. Journal of the American Academy of Dermatology. 2013;69(2):245-52.
  11. Reich K, Kruger K, Mossner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. The British journal of dermatology. 2009;160(5):1040-7.
  12. Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaci D, Behrens F, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. Journal of the American Academy of Dermatology. 2013;69(5):729-35.
  13. Menter A, Griffiths CE. Current and future management of psoriasis. Lancet (London, England). 2007;370(9583):272-84.
  14. Armstrong AW, Robertson AD, Wu J, Schupp C, Lebwohl MG. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011. JAMA dermatology. 2013;149(10):1180-5.
  15. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. Journal of the American Academy of Dermatology. 2011;65(1):137-74.
  16. Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. Journal of the American Academy of Dermatology. 2001;45(4):487-98; quiz 99-502.
  17. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. Journal of the American Academy of Dermatology. 2008;58(5):826-50.
  18. Schmitt J, Rosumeck S, Thomaschewski G, Sporbeck B, Haufe E, Nast A. Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. The British journal of dermatology. 2014;170(2):274-303.
  19. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. Journal of the American Academy of Dermatology. 2010;62(1):114-35.
  20. Nevitt GJ, Hutchinson PE. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. The British journal of dermatology. 1996;135(4):533-7.
  21. Perrott SB, Murray AH, Lowe J, Mathieson CM. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. Physiology & behavior. 2000;70(5):567-71.